INTRODUCTION
Many techniques for fistula-in-ano treatment have been reported. The goal of surgical treatment of a fistula-in-ano is to heal the fistula tract with the lowest rate of recurrence while still maintaining continence. The standard surgical treatment of fistulas-in-ano is an anal fistulotomy, which involves laying open the fistula tract and any associated sphincter muscle. Despite being properly performed, fistulotomy wounds can have prolonged healing times which can result in contour defects around the anus and they can also cause postoperative discomfort [1] . The other techniques (seton application, flap, etc) also have a long treatment period and are skilled operative techniques. In addition, Lunniss et al. [2] have shown that even a minimal division of the anal sphincter muscle during a fistulotomy can be associated with changes in fecal continence. Given these results, investigators have thus sought simpler sphincter muscle-sparing techniques to treat fistulasin-ano [1] .
Recently, the use of tissue adhesives or sealants in surgery has increased because of improved autologous and thesurgery.or.kr commercially available products [1, [3] [4] [5] . Fibrin glue application can be a valuable adjunct to surgical procedures in the treatment of fistula-in-ano. Fibrin glue is a biological glue made up of fibrinogen and its multiple components [6] . The end product is a gel-like substance that can be used in surgery to achieve hemostasis and a water tight seal [7] .
The purpose of this study was to ascertain the effectiveness of commercially available fibrin glue in closing fistula-in-ano at the long-term period.
METHODS
This prospective clinical study was carried out on 47 patients undergoing commercial fibrin glue application in 
RESULTS
Over a five-year period, 46 consecutive patients were treated with commercial fibrin glue. The cause of the fistula-in-ano was cryptoglandular in all patients. All of the patients had one fistula tract. Forty-two (91.30%) of the fistulas were transsphincteric, and 4 (8.69%) were suprasphincteric. The average length of the fistula tracts were 5.4 cm with a range from 4.1 to 13.2 cm.
Our initial success rate was 40 of 46 closures (86.95%).
They were transspincteric and suprasphincteric, 37 (88.09%) and 3 (75.00%), respectively. A second injection was needed in six patients (13.00%) because fistulas recurred between 2 and 9 weeks. All recurrence cases were transsphincteric except one. All recurrence patients were offered another attempt at fistula sealing using fibrin glue.
Only two patients accepted the second application. One of these had a low transsphincteric fistula, and the other had a high transsphincteric fistula. These two patients underwent a second application of fibrin glue, thus resulting in a total resolution of the symptoms and a healing of the fistulous tracts. Repeated fibrin glue treatments were successful for both patients. Values are presented as number (%). went a seton-fistulotomy as these fistulas were high transsphincteric types.
In total, 19 recurrences were observed initially. Another application was recommended to these patients. Two patients were accepted. In these two patients, the second application was successful. Seton was applied to the remaining 17 cases. These setons were ended with seton fistulotomy sooner than 4 weeks. In 4 cases, the setons were Table 2 .
DISCUSSION
Over the years, many papers have been published on the use of fibrin glue in different specialties of surgery. The use of fibrin glue in the treatment of fistulas-in-ano was first reported in the early 1980's with reasonable results [9, 10] . Since 1991, several articles have been published with favorable results using fibrin glue for the treatment of fistulas-in-ano [11] [12] [13] .
Complications following a surgical repair for fistula-in-ano can be devastating for patients. Flatus incontinence may be a minor complication for the surgeon but it could be very embarrassing for the patient [14] . Therefore, it is prudent to look for other ways in treating fistulas- faster return to normal activities with minimum operative trauma and no complication [7, 14, 15] . Some studies which were performed using conventional surgery techniques reported fistula treatment rates from 44 to 78 percent [15] .
The overall success rate may be low but an acceptable rate for success in this study.
Although this study has a limited number of patients it has a long follow-up period. It was thought these results could be important to support former, optimistic studies and new planning studies. The patients tolerated the injection procedure very well, and there were no complications resulting from this treatment, and no patient had any change in continence. In addition, no wound pain or discomfort was observed. The results regarding the advantages of fibrin glue were similar to those found in the literature.
The heterogeneity of the clinical trials made direct comparisons difficult. If our results are compared with other similar studies, then some differences exist between the results (Table 3 ) [1, 3, [15] [16] [17] [18] [19] [20] [21] . These differences, however, may be explained by their patient selection, their exclusive use of autologous fibrin glue that has a lower fibrinogen concentration, differences in the standardization of these products, which may thus not form as strong a plug as the commercial fibrin sealant may have, also contributed to their lower success rate. Furthermore, fistula characteristics are important factors combined with differences of complex or recurrent, primer and solitary, long or short. It is certainly possible that the success rate for treating complex and recurrent fistulas-in-ano is indeed, lower, because these types of fistulas have a lot of ramifications.
Finding the original fistula tract can also be difficult if it is a high level recurrent fistula. In addition, it is also possible that the application techniques may differ. Certainly a relatively small infection within the fistula tract could dislodge the fibrin glue plug and thus result in treatment failure. In this study, all patients had fistulas-in-ano with a cryptoglandular origin. Commercial fibrin glue was used.
All of the fistulas were non-complex, primer, solitary. technical problems due to lack of experience and a failure of antibiotics to eradicate all bacteria trapped in the clots in the fistula [6] [7] [8] [9] [10] [11] [12] [13] . There were 6 early recurrences in this study. It was suspected that in recurrent cases, the most probable causes were considered to be misdiagnosis or incorrect examination of the fistula tract preoperatively, technical problems, early oral intake postoperatively or infection in the tract. We have also observed that short fistula tracts respond poorly to fibrin glue injections, and the fistula tract length was approximately 4 cm in most of the recurrent cases. We found that the commercial fibrin glue succeeded more in cases longer than 4 cm with solitary fistulas during the five-year follow-up period. We thought there might also be technical problems in first few cases due to a lack of experience. It was also thought that early postoperative oral intake and the prediction of an infection in the tract might dislodge the fibrin glue plug.
Two recurrent cases were also treated with second applications in this study. The total number of recurrences was 17. Despite impressive early results, we saw the success rate drop at the end of the follow-up period. However, this result is good because fibrin glue has many advantages, the most important of which is continence.
Whether fibrin glue can cure all types of fistulae remains controversial [11] . High anal fistulas are among the most difficult problems faced in colorectal surgery. A fistulotomy is not advised for these fistulas, because treatment and continence are competing priorities, and fistulotomy leads to an unacceptable risk of incontinence. In this study, long solitary non-ramificate fistula tracts tended to show good results with fibrin glue.
Fibrin glue in the treatment of fistulae-in-ano has been previously explored and the availability of commercial fibrin glue has also improved [3, [16] [17] [18] . As a result, the success and recurrences rates were thus considered to be acceptable. However, long-term results were lower than our preliminary results.
Fibrin glue represents a new option in the management of the various types of fistulas-in-ano [19, 22] . It has enjoyed recent success in a series of selected patients.
Healing rates of up to 80 percent for cryptoglandular have also been reported (usually preliminary results). It can heal fistulas without jeopardizing anal continence, and if it fails, it can be repeated several times if required. Additionally, it does not preclude or alter subsequent treatment options [19] . Our practice and results are also similar to those reported in the literature.
In conclusion, fibrin glue injection is a feasible, valuable, In this study, we reported a 63.04% success rate in closing fistulas-in-ano with a sphincter muscle-sparing technique using fibrin glue over the long period. This technique has many advantages as mentioned above. This study also indicates that fibrin glue application is a simple, easily applicable, repeatable and safe for the treatment of fistula-in-ano. Thereafter, we should not only consider the success rate of commercial fibrin glue but the very important advantage of the muscle sparing techniques. It must be thought of as a preliminary option particularly for cryptoglandular and long fistulas. We think that some points must be observed with fibrin glue in anorectal fistulas for success. The most important factors are: fistula to be cryptoglanduler, to be solitary and long tracted, to prepare the bowel completely, to apply single dose parenteral anti- However, future investigations may be necessary to determine the most effective fibrin glue type and the optimal application technique to improve these results. Comparative studies also must establish which technique is most suitable on first application.
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